M
Magellan Health Inc
F:MAH1
Magellan Health Inc
F:MAH1
Price:
83.5
EUR
Market Cap:
€2.2B
Relative Value
There is not enough data to reliably calculate the relative value of MAH1.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MAH1
Relative Value
Base Case
Not Available
Multiples Across Competitors
MAH1 Competitors Multiples
Magellan Health Inc Competitors
Magellan Health Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 0.5 | 8.5 | 12.9 | 38.5 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
255.8B USD | 0.6 | 21.2 | 0 | 0 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
73.6B USD | 0.4 | 12.9 | 0 | 0 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
62.4B USD | 0.3 | 11 | 0 | 0 | |
| US |
|
Humana Inc
NYSE:HUM
|
20.9B USD | 0.2 | 17.6 | 0 | 0 | |
| US |
|
Centene Corp
NYSE:CNC
|
17.9B USD | 0.1 | -2.7 | 0 | 0 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
7.2B USD | 0.2 | 15.3 | 3 | 3.7 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.7B USD | 5.2 | 35 | 16.3 | 24.7 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 1.1 | 25 | 12.1 | 12.7 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
7.6B BRL | 3.1 | 13 | 8.7 | 9.5 | |
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1B USD | 0.6 | -17.4 | -14.5 | -14.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
